Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BioXcel Therapeutics Inc. (BTAI)

36.97   13.12 (55.01%) 02-14 16:00
Open: 38.73 Pre. Close: 23.85
High: 41.51 Low: 32
Volume: 4,691,882 Market Cap: 667M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 41.561 - 41.715 41.715 - 41.839
Low: 31.671 - 31.825 31.825 - 31.948
Close: 36.708 - 36.977 36.977 - 37.194

Technical analysis

as of: 2020-02-14 4:27:09 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 48.48     One year: 56.63
Support: Support1: 23.43    Support2: 12.25
Resistance: Resistance1: 41.51    Resistance2: 48.48
Pivot: 20.25
Moving Average: MA(5): 24.47     MA(20): 19.47
MA(100): 9.99     MA(250): 10.03
MACD: MACD(12,26): 3.35     Signal(9): 2.24
Stochastic oscillator: %K(14,3): 73.32     %D(3): 75.42
RSI: RSI(14): 85.23
52-week: High: 41.51  Low: 3.76  Change(%): 318.7
Average Vol(K): 3-Month: 38168  10-Days: 89159

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BTAI has closed above the upper band by 35.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 301.3% wider than normal. The large width of the bands suggest high volatility as compared to BTAI's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL ) AtriCure Inc. (NASDAQ: ATRC ) Beam Therapeutics Inc (NASDAQ: BEAM ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fortress Biotech (NASDAQ: FBIO ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Masimo Corporation (NASDAQ: MASI ) NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Recro Pharma Inc (NASDAQ: REPH ) ResMed Inc. (NYSE: RMD ) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Thursday) Syneos Health Inc (NASDAQ: SYNH ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Taro Pharmaceutical Industries Ltd. (NYSE: TARO ) West Pharmaceutical Services Inc.

Stock Alert: BioXcel Therapeutics (BTAI)
BioXcel Therapeutics Inc. (BTAI), which had a banner year in 2019, gaining a whopping 338%, is up an impressive 50% so far this year..

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 18.04
Shares Float (M) 8.25
% Held by Insiders 53.84
% Held by Institutions 28.07
Shares Short (K) 582
Shares Short P. Month (K)

Stock Financials

EPS -2.030
Book Value (p.s.) 1.910
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -44.4
Return on Equity (ttm) -79.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.795
Qtrly Earnings Growth
Operating Cash Flow (M) -23.70
Levered Free Cash Flow (M) -13.50

Stock Valuations

P/E -18.21
P/E Growth Ratio 0.55
P/BV 19.36
P/CF -28.14

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.